Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Prog Cardiovasc Dis Retrieve available abstracts of 29 articles: HTML format Text format

Single Articles

November 2018
1. OZEMEK C, Laddu DR, Lavie CJ, Claeys H, et al
   An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk.
   Prog Cardiovasc Dis. 2018 Nov 13. pii: S0033-0620(18)30220.
   PubMed     Text format     Abstract available
   
   
   July 2018
2. AWERBACH JD, Krasuski RA, Camitta MGW
   Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?
   Prog Cardiovasc Dis. 2018 Jul 21. pii: S0033-0620(18)30151.
   PubMed     Text format     Abstract available
   
   
   
3. ELAGIZI A, Kachur S, Lavie CJ, Carbone S, et al
   An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
   Prog Cardiovasc Dis. 2018 Jul 5. pii: S0033-0620(18)30130.
   PubMed     Text format     Abstract available
   
   
   
4. BARRY VW, Caputo JL, Kang M
   The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis.
   Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30131.
   PubMed     Text format     Abstract available
   
   
   
5. RUIZ JR, Martinez-Tellez B, Sanchez-Delgado G, Osuna-Prieto FJ, et al
   Role of Human Brown Fat in Obesity, Metabolism and Cardiovascular Disease: Strategies to Turn Up the Heat.
   Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30129.
   PubMed     Text format     Abstract available
   
   
   
6. ORTEGA FB, Lavie CJ
   Introduction and Update on Obesity and Cardiovascular Diseases 2018.
   Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30137.
   PubMed     Text format    
   
   
   June 2018
7. PICHE ME, Poirier P, Lemieux I, Despres JP, et al
   Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.
   Prog Cardiovasc Dis. 2018 Jun 28. pii: S0033-0620(18)30122.
   PubMed     Text format     Abstract available
   
   
   
8. ENGLISH WJ, Williams DB
   Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease.
   Prog Cardiovasc Dis. 2018 Jun 25. pii: S0033-0620(18)30121.
   PubMed     Text format     Abstract available
   
   
   May 2018
9. CHIAVAROLI L, Nishi SK, Khan TA, Braunstein CR, et al
   Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
   Prog Cardiovasc Dis. 2018 May 25. pii: S0033-0620(18)30094.
   PubMed     Text format     Abstract available
   
   
   
10. KAHLEOVA H, Levin S, Barnard ND
    Vegetarian Dietary Patterns and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30087.
    PubMed     Text format     Abstract available
    
    
    
11. BITOK E, Sabate J
    Nuts and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30092.
    PubMed     Text format     Abstract available
    
    
    
12. SIEVENPIPER JL, Lavie CJ
    Dietary Prevention of Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 May 4. pii: S0033-0620(18)30085.
    PubMed     Text format    
    
    
    April 2018
13. SALAS-SALVADO J, Becerra-Tomas N, Garcia-Gavilan JF, Bullo M, et al
    Mediterranean Diet and Cardiovascular Disease Prevention: What do We Know?
    Prog Cardiovasc Dis. 2018 Apr 17. pii: S0033-0620(18)30074.
    PubMed     Text format     Abstract available
    
    
    
14. KIM ESH, Beckman JA
    Introduction to the Vascular Medicine Issue of Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30069.
    PubMed     Text format    
    
    
    
15. AGRAWAL V, Kim ESH
    Spontaneous Coronary Artery Dissection: Cardiac Manifestations of Vascular Disease.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30067.
    PubMed     Text format     Abstract available
    
    
    March 2018
16. ELAGIZI A, Lavie CJ, Marshall K, DiNicolantonio JJ, et al
    Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health: A Comprehensive Review.
    Prog Cardiovasc Dis. 2018 Mar 20. pii: S0033-0620(18)30061.
    PubMed     Text format     Abstract available
    
    
    February 2018
17. KERNEIS M, Talib U, Nafee T, Daaboul Y, et al
    Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2018 Feb 2. pii: S0033-0620(18)30028.
    PubMed     Text format     Abstract available
    
    
    January 2018
18. EFFRON MB, Gibson CM
    The waxing and waning of antithrombotic therapy in cardiovascular disease - Where is the moon now?
    Prog Cardiovasc Dis. 2018 Jan 21. pii: S0033-0620(18)30032.
    PubMed     Text format    
    
    
    
19. DINICOLANTONIO JJ, Liu J, O'Keefe JH
    Thiamine and cardiovascular disease: A literature review.
    Prog Cardiovasc Dis. 2018 Jan 19. pii: S0033-0620(18)30029.
    PubMed     Text format     Abstract available
    
    
    
20. TANTRY U, Navarese EP, Myat A, Gurbel P, et al
    Selection of P2Y12 inhibitor in percutaneous coronary intervention and/or acute coronary syndrome.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30020.
    PubMed     Text format     Abstract available
    
    
    
21. ZEITOUNI M, Kerneis M, Nafee T, Collet JP, et al
    Anticoagulation in acute coronary syndrome-state of the art.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30021.
    PubMed     Text format     Abstract available
    
    
    
22. VIDULA MK, Secemsky EA, Yeh RW
    Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Text format     Abstract available
    
    
    
23. EFFRON MB, Gibson CM
    Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Text format     Abstract available
    
    
    
24. GOLWALA H, Bhatt DL
    The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Text format     Abstract available
    
    
    December 2017
25. SARBACKER GB, Lusk KA, Kalich B
    Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease in Adults 80-Years-of-Age and Older.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30168.
    PubMed     Text format    
    
    
    
26. MOON JY, Franchi F, Rollini F, Angiolillo DJ, et al
    Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30166.
    PubMed     Text format     Abstract available
    
    
    
27. SHARMA A, Garg A, Elmariah S, Drachman D, et al
    Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Prog Cardiovasc Dis. 2017 Dec 22. pii: S0033-0620(17)30165.
    PubMed     Text format     Abstract available
    
    
    November 2017
28. KARIO K, Tomitani N, Kanegae H, Yasui N, et al
    Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project.
    Prog Cardiovasc Dis. 2017 Nov 3. pii: S0033-0620(17)30142.
    PubMed     Text format     Abstract available
    
    
    September 2017
29. HERMAN ME, O'Keefe JH, Bell DSH, Schwartz SS, et al
    Insulin Therapy Increases Cardiovascular Risk: Time for a Sea of Change in Type 2 Diabetes Treatment.
    Prog Cardiovasc Dis. 2017 Sep 25. pii: S0033-0620(17)30139.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: